Stem-cell therapy for aging

Stem-cell therapy for aging means infusing donor stem cells, usually mesenchymal stem cells, to restore some of the repair capacity the body loses with age. The best trial so far found a small, uncertain gain in walking distance at two of four doses, seen only at nine months. Meanwhile, thousands of clinics sell unapproved stem-cell injections with a documented record of serious harm.

Don't pay for stem-cell injections for aging or eye disease outside a registered clinical trial. The clinic treatments are not approved by the US Food and Drug Administration (FDA), none is established for healthy adults, and they have blinded and killed people.

What is being tried

Mesenchymal stem cells are support cells found in bone marrow, fat and umbilical cord. They are attractive for aging research because they are well tolerated and work largely by secreting repair-promoting factors rather than by permanently engrafting: they do not take up residence in the tissue. The idea is to top up the repair capacity that stem-cell exhaustion erodes.

The best trial so far: laromestrocel for frailty

The most advanced human data is in physical frailty. A placebo-controlled trial in 148 frail older adults tested four doses of donor bone-marrow stem cells (laromestrocel), each given as a single drip.^[1]

At six months, the main comparison of each dose against placebo on the walking test was not statistically significant, although the gains rose with dose.
By nine months the highest dose added about 63 metres to a six-minute walk, and a lower dose added about 49 metres.
But the highest-dose group had only 16 people, the other two doses showed no clear benefit, and gait speed, grip strength and self-reported function did not improve.
Safety: no serious side effects were blamed on the cells.
Who ran it: the company that makes the product, with a US government research grant. The corresponding author is the company's chief science officer and an equity holder.

That makes it one small trial on a walking test, with a conflicted sponsor: a signal, not proof.

What the other trials add

A 2026 review of the three placebo-controlled trials so far (about 208 people) found the cells well tolerated but judged the trials too few and too varied to say the treatment works.^[2] A later trial of umbilical-cord stem cells in 147 frail adults reported a gain of about 1 point on a 12-point physical-performance score, but it was open-label, ran at a single centre and compared the cells with supplements alone, with no placebo.^[3]

This is the strongest stem-cell-for-aging evidence to date, but it is not a proven anti-aging therapy, and intravenous cell delivery carries its own risks.

The unapproved clinics

In 2021, more than 2,700 clinics in the United States, run by about 1,500 businesses, were selling stem-cell treatments the FDA has never approved, more than four times as many businesses as in 2016.^[4]

The injuries are documented. A 2021 tally by the Pew Charitable Trusts, a US policy group, found reports of at least 360 people worldwide harmed between 2004 and 2020, including 20 deaths, 9 cases of partial or complete blindness and over 100 hospitalizations. That is probably an undercount, because these clinics rarely report harms.^[5] In one widely reported case, three women were blinded after a clinic injected fat-derived "stem cells" into their eyes for macular degeneration.^[6]

Related "young plasma" infusions are a separate trap, covered under plasma exchange.

What to do

Treat any clinic offering stem cells for aging as unproven and potentially dangerous, whatever the marketing says.
Never accept stem-cell injections into the eye outside a registered trial.
If you want to try a cell therapy, look for a registered, placebo-controlled trial rather than a paid service.